erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
the house has passed an order extending the public health committee's reporting deadline for cusack's bill. .
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital. .